Bavencio

MEDICAL INQUIRIES MEDICAL INQUIRIES

THERAPEUTIC AREAS THERAPEUTIC AREAS

DRUG PORTFOLIO DRUG PORTFOLIO

CONGRESSES AND PUBLICATIONS CONGRESSES AND PUBLICATIONS

Contact Us

Call 1-888-275-7376
(8-5:30 ET M-F)

Submit Med Info Request

Adverse Event:
1-800-283-8088, ext. 5563

eMedI Chat: Medical Information Database

Please click the eMedI Chat icon in the lower right corner of your screen to use our chatbot and search the Medical Information database

Temperature Stability Calculator

Have a question about a temperature excursion?

Find Your Medical Representative

Find your Medical Representative based on your therapeutic area and zip code.

Therapeutic Areas

Discover our resource library on diseases, products, congresses, publications, and more, organized by therapeutic areas

Disease Awareness

Find information on disease areas of interest

Marketed Products

Find information on our marketed products

Pipeline Agents

Find information on our pipeline agents

Congress Presentations

Explore our library of congress presentations

Journal Publications

Discover our library of select journal publications

eMedI Chat

BAVENCIO^® (avelumab) injection

Product Labeling

Prescribing Information

BAVENCIO^® (avelumab) injection

Medication Guide

BAVENCIO^® (avelumab) injection

Medical Slide Decks

Mechanism of Action

Overview of key disease mechanisms within tumor cells and the MoA of avelumab, an anti-programmed death ligand-1 (PD-L1) antibody | Slide Deck

JAVELIN Bladder 100 Overview

Summary of key data from the JAVELIN Bladder 100 trial including additional subgroup and patient-reported outcomes (PRO) analyses | Slide Deck

Avelumab Real-World Data in Urothelial Carcinoma

Summary of avelumab real-world data in patients with urothelial carcinoma | Slide Deck

JAVELIN Merkel 200 Overview

Summary of key data from the JAVELIN Merkel 200 trial including both 2L and 1L data | Slide Deck

JAVELIN Renal 101 Overview

Summary of key data from the JAVELIN Renal 101 trial | Slide Deck

Avelumab Safety

Summary of key safety data for avelumab | Slide Deck

Safety Data Sheet

Safety Data Sheet (SDS)

BAVENCIO^® (avelumab) injection

Patient Resources

Research

Additional Oncology Resources

BAVENCIO and CoverOne are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.

This site is intended for US healthcare professionals only.

DISCLAIMER: This site contains medical information that is intended for healthcare providers of the United States only. The medical information contained on this site is not meant to substitute for the advice provided by a medical professional. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.

US-MULNP-00046 07/25

By clicking this link, you are leaving medical.emdserono.com. Please, note that this link will take you to a website on which different Privacy Policy and Conditions may apply. EMD Serono accepts no responsibility for websites not controlled directly by us. Please check Privacy Policy and Conditions of the linked website.

Welcome to EMD Serono Medical Information!

Help us direct you to the right information by selecting one of the following options:

BAVENCIO® (avelumab) injection Product Labeling

Medical Slide Decks

Safety Data Sheet

Patient Resources

Research

Additional Oncology Resources

Welcome to EMD Serono Medical Information!

BAVENCIO^® (avelumab) injection

Product Labeling